Paper3124166
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Midha KK and 6 others. Psychopharmacology (Berl), 1987. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate. Papers, record 3124166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3124166
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluphenazine | Major topic |
| Schizophrenia | Major topic |
| Gas Chromatography-Mass Spectrometry | |
| Humans | |
| Male | |
| Radioimmunoassay |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,686,710 | Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study. | Prog Neuropsychopharmacol Biol Psychiatry | 1983 | https://conductscience.org/library/papers/6686710 | PubMed |
| 2 | 12,260 | Methods for study of fluphenazine kinetics in man. | J Pharm Pharmacol | 1976 | https://conductscience.org/library/papers/12260 | PubMed |
| 3 | 5,560,899 | Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. | Br J Pharmacol | 1971 | https://conductscience.org/library/papers/5560899 | PubMed |
| 4 | 5,073,041 | Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain. | Psychopharmacologia | 1972 | https://conductscience.org/library/papers/5073041 | PubMed |
| 5 | 3,085,136 | Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate. | Psychopharmacology (Berl) | 1986 | https://conductscience.org/library/papers/3085136 | PubMed |
| 6 | 20,313,533 | Fluphenazine, trifluoperazine and perphenazine in Vacutainers. | Can Med Assoc J | 1981 | https://conductscience.org/library/papers/20313533 | PubMed |
| 7 | 6,143,748 | Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. | J Clin Psychiatry | 1984 | https://conductscience.org/library/papers/6143748 | PubMed |
| 8 | 444,352 | Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/444352 | PubMed |
| 9 | 3,992,882 | Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose. | Vet Hum Toxicol | 1985 | https://conductscience.org/library/papers/3992882 | PubMed |
| 10 | 6,437,365 | Costs and benefits of two doses of fluphenazine. | Arch Gen Psychiatry | 1984 | https://conductscience.org/library/papers/6437365 | PubMed |
| 11 | 6,122,292 | Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects. | Ther Drug Monit | 1982 | https://conductscience.org/library/papers/6122292 | PubMed |
| 12 | 533,577 | Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/533577 | PubMed |
| 13 | 4,762,235 | The possible role of metabolites in therapeutic response to chlorpromazine treatment. | Psychopharmacologia | 1973 | https://conductscience.org/library/papers/4762235 | PubMed |
| 14 | 5,783,587 | Solid-phase radioimmunoassay of estradiol-17 beta. | J Clin Endocrinol Metab | 1969 | https://conductscience.org/library/papers/5783587 | PubMed |
| 15 | 4,403,854 | Effect of chlorpromazine and some of its metabolites on the accumulation of homovanilic acid in brain of mice. | J Pharm Pharmacol | 1972 | https://conductscience.org/library/papers/4403854 | PubMed |
| 16 | 5,026,403 | Effect of various chlorpromazine metabolites on amphetamine-induced stereotyped behaviour in the rat. | Eur J Pharmacol | 1972 | https://conductscience.org/library/papers/5026403 | PubMed |
| 17 | 631,182 | 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives. | Eur J Pharmacol | 1978 | https://conductscience.org/library/papers/631182 | PubMed |
| 18 | 6,129,552 | Metabolic interaction between perphenazine and disulfiram. | Lancet | 1982 | https://conductscience.org/library/papers/6129552 | PubMed |
| 19 | 7,194,019 | behavior of rats and mice administered active metabolites of fluphenazine, 7-hydroxy-fluphenazine and fluphenazine-sulfoxide. | Arch Int Pharmacodyn Ther | 1980 | https://conductscience.org/library/papers/7194019 | PubMed |
| 20 | 6,719,481 | Thioridazine-5-sulfoxide cardiotoxicity in the isolated, perfused rat heart. | Toxicol Lett | 1984 | https://conductscience.org/library/papers/6719481 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,918,346 | Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. | J Psychiatry Neurosci | 1994 | https://conductscience.org/library/papers/7918346 | PubMed |
| 2,570,430 | Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2570430 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3124166
GET https://conductscience.org/api/papers/v1/3124166/references?page=2